source
- HHS launches funding programs to accelerate U.S. clinical trials amid rising Chinese competitionHHS announced new initiatives aimed at speeding up clinical trial development in the United States. The department introduced a five-year program called "Surpass" that seeks proposals from teams wi…
- Final Medicare rule to curb doctor-administered drug prices covers only four firms, delivering far less savings than proposedThe Trump administration released a final rule intended to lower Medicare prices for drugs given in doctors' offices. The rule applies only to four pharmaceutical companies, a far narrower scope t…